Vaccines boosters and mandates


Future Files

9/2/2021, 8:03:45 AM

In light of vaccine passports mandates and booster rollouts this fall, let’s take a blitz review of available Sarscov2 vaccines in the western markets The Oxford–AstraZeneca COVID-19 vaccine is based on the modified chimpanzee adenovirusChAdOx1 as a vector. According to studies, AZN vaccines have the lowest efficacy vs numerous variants and a series of neurological and clotting adverse effects.

Johnson&Johnson/janssen is a viral vector vaccine based on a HUMAN adenovirus expressing SARS-CoV-2) spike stabilized (S) protein with furin cleavage site (FCS)knockout.

Moderna and Pfizer vaccines are the mRNA based vaccines with furin site inclusion containing lipid nanoparticles and modified nucleosides deceiving hosts immune system for cell entry it is likely Viral mRNA and mRNA vaccine components repeated use present additional cytotoxic and immunosuppressive risks, concerning gene expression regulation aspect, innate cell defense mechanism disruption as noted last year via expected boosters due to short durability and viral mutability and adaptability

To summarise, there is no sufficient data collected for mandating vaccines or boosters with currently observed rising mutability climbing to peak viral fitness, viral vaccine escape and breakthrough infections due to new mutations emergence. It is worth to note that mRNA platform is a suitable option for rare genetic diseases&some experimental cancer treatments. On another hand, mandating mRNA repeated use it for millions and even billions of people without long term studies and disclosing all potential risks to those who don’t understand its implications is harmful given ubiquitous post infection and cross reactive natural immunity protection in most.

Something to take in consideration should be the joint US government ownership of stabilized coronavirus S spike protein for vaccine patents from 2016-2021 with moderna used in Sarscov2 mRNA vaccines Axios had reported last spring, “NIH said in a statement that its scientists created the "stabilized coronavirus spike proteins for the development of vaccines against coronaviruses, including SARS-CoV-2," in 2016 and filed related patents in October 2016, 2017 and 3/8/2021... the government consequently has "sought patents to preserve the government's rights to these inventions."

Cumulative immunosuppression, ADE probability ⬆️ after exposure to other vaccines!infections are among risks and may take 12-36mo for cell differentiation/RNA interference&gene regulation disruption to lead to increase in neurodegenerative diseases ⬆️hematological malignancies incidence